Detrimental Impact of Energy Drink Compounds on Developing Oligodendrocytes and Neurons.
caffeine
energy drinks
neuron
oligodendrocytes
taurine
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
03 11 2019
03 11 2019
Historique:
received:
26
09
2019
revised:
30
10
2019
accepted:
31
10
2019
entrez:
6
11
2019
pubmed:
7
11
2019
medline:
9
7
2020
Statut:
epublish
Résumé
The consumption of energy drinks is continuously rising, particularly in children and adolescents. While risks for adverse health effects, like arrhythmia, have been described, effects on neural cells remain elusive. Considering that neurodevelopmental processes like myelination and neuronal network formation peak in childhood and adolescence we hypothesized that developing oligodendrocytes and neurons are particularly vulnerable to main energy drink components. Immature oligodendrocytes and hippocampal neurons were isolated from P0-P1 Wistar rats and were incubated with 0.3 mg/mL caffeine and 4 mg/mL taurine alone or in combination for 24 h. Analysis was performed immediately after treatment or after additional three days under differentiating conditions for oligodendrocytes and standard culture for neurons. Oligodendrocyte degeneration, proliferation, and differentiation were assessed via immunocytochemistry and immunoblotting. Neuronal integrity was investigated following immunocytochemistry by analysis of dendrite outgrowth and axonal morphology. Caffeine and taurine induced an increased degeneration and inhibited proliferation of immature oligodendrocytes accompanied by a decreased differentiation capacity. Moreover, dendritic branching and axonal integrity of hippocampal neurons were negatively affected by caffeine and taurine treatment. The negative impact of caffeine and taurine on developing oligodendrocytes and disturbed neuronal morphology indicates a high risk for disturbed neurodevelopment in children and adolescents by excessive energy drink consumption.
Identifiants
pubmed: 31684159
pii: cells8111381
doi: 10.3390/cells8111381
pmc: PMC6912672
pii:
doi:
Substances chimiques
Taurine
1EQV5MLY3D
Caffeine
3G6A5W338E
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Dev Neurobiol. 2012 Jan;72(1):73-86
pubmed: 21761575
Eur J Pediatr. 2017 May;176(5):599-605
pubmed: 28229268
Med Sci Monit. 2019 Mar 06;25:1729-1739
pubmed: 30840612
CMAJ Open. 2018 Jan 9;6(1):E19-E25
pubmed: 29335277
PLoS One. 2012;7(11):e49023
pubmed: 23155446
Front Cell Neurosci. 2012 Dec 28;6:61
pubmed: 23293584
Food Chem Toxicol. 2012 Oct;50(10):3759-68
pubmed: 22809471
Nat Protoc. 2012 Sep;7(9):1741-54
pubmed: 22936216
Nature. 2001 Mar 15;410(6826):372-6
pubmed: 11268214
Br J Nutr. 2018 Apr;119(7):826-835
pubmed: 29569537
Cancer Res. 2003 Aug 1;63(15):4396-401
pubmed: 12907610
Science. 2005 Feb 25;307(5713):1282-8
pubmed: 15731448
Sci Rep. 2017 Sep 13;7(1):11458
pubmed: 28904364
Int J Mol Sci. 2018 Jan 24;19(2):null
pubmed: 29364139
Brain Behav Immun. 2016 Feb;52:106-119
pubmed: 26456693
Amino Acids. 2001;20(1):75-82
pubmed: 11310932
J Comp Neurol. 1965 Jun;124(3):319-35
pubmed: 5861717
Eur J Pediatr. 2013 Oct;172(10):1335-40
pubmed: 23708215
Toxicol Appl Pharmacol. 1983 Nov;71(2):237-41
pubmed: 6636188
World J Clin Pediatr. 2015 Nov 08;4(4):81-93
pubmed: 26566480
Food Chem Toxicol. 2019 Aug;130:109-121
pubmed: 31112702
J Korean Med Sci. 2002 Oct;17(5):674-8
pubmed: 12378022
PLoS One. 2012;7(8):e42935
pubmed: 22916184
Nat Neurosci. 1999 Oct;2(10):861-3
pubmed: 10491603
Annu Rev Neurosci. 2010;33:349-78
pubmed: 20367247
Int J Mol Sci. 2017 Jan 18;18(1):
pubmed: 28106777
Eur J Nutr. 2014 Oct;53(7):1561-71
pubmed: 24474552
Hum Brain Mapp. 2019 Oct 15;40(15):4345-4356
pubmed: 31282058
J Cell Biol. 1980 Jun;85(3):890-902
pubmed: 6248568
Front Cell Neurosci. 2013 Dec 19;7:256
pubmed: 24391540
Pediatrics. 2011 Mar;127(3):511-28
pubmed: 21321035
Neurochem Res. 2005 Dec;30(12):1483-92
pubmed: 16362767
Prog Neurobiol. 2013 Jul-Aug;106-107:1-16
pubmed: 23583307
Front Behav Neurosci. 2014 Apr 01;8:106
pubmed: 24744707
CNS Neurosci Ther. 2017 Apr;23(4):272-290
pubmed: 28317317
Cytometry A. 2004 Apr;58(2):167-76
pubmed: 15057970
J Food Sci. 2017 Apr;82(4):1037-1043
pubmed: 28304088
Cold Spring Harb Protoc. 2016 Nov 1;2016(11):
pubmed: 27803251
Adv Exp Med Biol. 2017;975 Pt 1:281-292
pubmed: 28849463
Oxid Med Cell Longev. 2013;2013:791795
pubmed: 23766861
J Neurochem. 2002 Dec;83(5):1188-95
pubmed: 12437590
Clin Toxicol (Phila). 2016;54(4):308-12
pubmed: 27100333
Birth Defects Res. 2017 Dec 1;109(20):1640-1648
pubmed: 29251842
Neuron. 2018 Aug 22;99(4):689-701.e5
pubmed: 30078577
Biomed Pharmacother. 2018 Jun;102:798-811
pubmed: 29605768
Int J Sports Med. 2009 Jul;30(7):485-8
pubmed: 19455480
Free Radic Biol Med. 2014 Feb;67:221-34
pubmed: 24129198
Trends Cell Biol. 1993 Jun;3(6):191-7
pubmed: 14731493
Bioessays. 2015 Jan;37(1):60-9
pubmed: 25363888
Front Neurosci. 2011 Oct 21;5:116
pubmed: 22025909
Oncol Lett. 2018 Apr;15(4):5473-5480
pubmed: 29552188
J Pharmacol Exp Ther. 1989 Mar;248(3):1078-83
pubmed: 2539455